Akso Health Group
AHG
$1.28
-$0.12-8.57%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | -10.77% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | -10.77% | |||
| Cost of Revenue | 0.00% | -23.35% | |||
| Gross Profit | 0.00% | 231.34% | |||
| SG&A Expenses | 0.00% | -29.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.00% | -24.85% | |||
| Operating Income | 0.00% | 57.50% | |||
| Income Before Tax | 0.00% | 99.13% | |||
| Income Tax Expenses | 0.00% | 99.55% | |||
| Earnings from Continuing Operations | 0.00% | 99.04% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.00% | -95.21% | |||
| Net Income | 0.00% | 99.05% | |||
| EBIT | 0.00% | 57.50% | |||
| EBITDA | 0.00% | 82.95% | |||
| EPS Basic | 0.00% | 99.45% | |||
| Normalized Basic EPS | 0.00% | 69.57% | |||
| EPS Diluted | 0.00% | 99.26% | |||
| Normalized Diluted EPS | 0.00% | 69.57% | |||
| Average Basic Shares Outstanding | 0.00% | 74.72% | |||
| Average Diluted Shares Outstanding | 0.00% | 74.72% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||